UK Startup Funding Report: £2647.3m raised across AI, Healthtech and Data (28 Sept–2 Oct 2026).
It's Friday, 2 October, and this is your UK Startup Funding Report.
This week saw major rounds across AI, healthtech and data businesses, including a multi‑billion pre‑IPO debt package and a raft of growth and seed deals. Total reported UK startup funding for the period was £2647.3M.
AI: productisation meets compute infrastructure
Startups building large models, agentic systems and the underlying AI infrastructure dominated the headlines this week. Investors are splitting their commitments between productised applications that reach customers today and the heavy compute and cloud platforms that require longer lead times and greater capital intensity.
Deals illustrate that divide. Nscale closed a convertible loan note of about £2.54 billion led by Third Point to accelerate global data centre build‑outs and expand its vertically integrated AI cloud platform. Metaview raised £45 million in a series C led by Insight Partners to scale its agentic recruiting tools and roll autonomous hiring assistants into general availability. Seed‑level funding also landed: Zenithon secured £7.5 million led by BACKED to train large world models for 'extreme physics', while ClearDraft accepted a strategic, undisclosed investment from News UK to embed its AI‑assisted legal clearance tool into newsroom workflows.
Taken together, the rounds span the full lifecycle from seed research plays to pre‑IPO debt. The picture is clear: capital is available both for rapid productisation and for the substantial, long‑term investment needed to build compute and cloud infrastructure, with a noticeable concentration of activity in London.
This week's AI & Machine Learning deals:
Nscale closed a £2,539,110,000 convertible loan note package led by Third Point, with a further NVIDIA commitment expected later in the year. The debt is a pre‑IPO instrument intended to accelerate global data centre build‑outs and expand its vertically integrated AI cloud platform.
Metaview raised £45,000,000 in a series C led by Insight Partners to scale its agentic recruiting platform and roll autonomous hiring assistants into general availability. The round brings lifetime funding close to £85m as the company expands headcount and opens a New York office.
Zenithon raised £7,500,000 in a seed round led by BACKED to train large world models for 'extreme physics' and scale research and delivery teams in London and the US. The capital will be split between hiring and compute to speed development in areas like fusion, hypersonics and advanced chip design.
ClearDraft received a strategic investment from News UK to embed its AI‑assisted legal clearance tool across newsroom workflows; the company did not disclose the amount. The partnership will help train the product for newsroom lawyers and speed routine legal sign‑off while keeping final decisions with human lawyers.
Healthtech: pragmatic funding for clinical rollout
Investors and grantmakers this week favoured diagnostics, clinical automation and simulation‑led medtech that promise to reduce bottlenecks, improve training and make unstructured clinical data usable. The emphasis is on solutions that can clear regulatory hurdles and integrate into existing workflows.
Several targeted financings exemplify that approach. Inovus Medical closed a £15 million growth round to accelerate US expansion and extend its surgical simulator hardware and TOTUM software into new specialties. DYAD raised £7.5 million in a series A led by Sangha Capital to roll out BetterLetter in UK general practice and to pilot its GENIE system in secondary care and mental‑health settings. Cambridge spin‑out 52North secured £3.2 million in grant and institutional funding to advance clinical validation and regulatory milestones for Neutrocheck, a rapid finger‑prick test for triaging chemotherapy patients at risk of neutropenic sepsis, while Occam Industries raised about £3.26 million in seed funding to scale production of precision gimbals for imaging and robotic platforms.
The pattern is deliberate: a mix of growth rounds and targeted grants aimed at regulatory proof and commercial rollout. Investors are prioritising tools that slot into clinical workflows and address clearly defined bottlenecks rather than speculative bets.
This week's Healthtech & Biotech deals:
St Helens‑based Inovus Medical closed a £15,000,000 growth round to accelerate US expansion and extend its surgical simulator hardware and TOTUM software into new specialties. The funding will support commercial rollout and further product development for training programmes used across the NHS and North America.
DYAD closed a £7,500,000 series A led by Sangha Capital to accelerate rollout of BetterLetter in UK general practice and pilot its GENIE system in secondary care and mental health settings internationally. The funding will support product deployment and scaling of its clinical information extraction platform.
Cambridge spin‑out 52North secured £3,200,000 in grant and institutional funding to progress clinical validation and regulatory milestones for Neutrocheck, a rapid finger‑prick test to triage chemotherapy patients at risk of neutropenic sepsis. The funding is targeted at studies and UK market preparation.
Occam Industries (M‑Fly) raised the equivalent of £3,260,000 in seed funding to scale production of precision gimbals used in imaging and robotic platforms. The capital will be used to expand manufacturing capacity, quality control and supplier integration for volume production.
Space: investing in ground infrastructure and precision positioning
This week’s space financings emphasised commercialising ground infrastructure and precision‑positioning services. Investors are backing companies that combine in‑house hardware, manufacturing and data platforms to support navigation, traffic management and high‑precision Earth observation.
Foundational raised £8 million in a pre‑seed round to build a global ground‑station network, bring retroreflector manufacturing in‑house and expand its precision positioning data platform for satellite applications. Backers cited the potential to commercialise satellite laser ranging for navigation, space traffic management and Earth observation.
The deal underlines a broader trend: early‑stage capital is flowing to capital‑intensive, vertically integrated plays that can deliver both hardware and data services, rather than to software‑only propositions.
This week's Space & Satellite deals:
Foundational raised £8,000,000 in a pre‑seed round to build a global ground‑station network, bring retroreflector manufacturing in‑house and expand its precision positioning data platform for satellite applications. Investors backed the company’s plan to commercialise satellite laser ranging for navigation, space traffic management and Earth observation.
Mobility and defence: industrialisation over prototypes
Funding this week favoured asset‑heavy transport and autonomous platforms that are moving from demonstrators to industrial products. Investors are financing certification, production readiness and the software‑driven asset management layers that make hardware commercially viable.
Certo Aerospace raised £5 million to industrialise its Capstone heavy‑lift uncrewed aircraft, advancing engineering work for repeatable manufacture and certification. DriveSimple secured £1.5 million in a seed round led by Calm Media Investments to grow its flexible van subscription fleet, introduce electric vehicles and develop an AI underwriting platform to speed credit and underwriting decisions for SME customers.
The common theme is clear: capital is being directed at the hard work of industrialisation — scaling production, achieving regulatory certainty and building the software that enables reliable, repeatable operations for both commercial and defence customers.
This week's Mobility & Defence deals:
Certo Aerospace raised £5,000,000 to industrialise its Capstone heavy‑lift uncrewed aircraft and move from demonstrator to production‑ready designs. The money will fund engineering work needed for repeatable manufacture, certification and operational use after several years of flight testing and defence demonstrations.
DriveSimple raised £1,500,000 in a seed round led by Calm Media Investments to grow its flexible van subscription fleet, introduce electric vehicles and develop an AI underwriting platform. The capital will be used to scale inventory and speed up credit and underwriting decisions for SME customers.
Consumer brands back regional traction before scale
Investors continue to favour founder‑led consumer brands that demonstrate repeatable retail performance and efficient local growth. The prevailing strategy is to prove concepts regionally before committing to national rollouts.
Something & Nothing raised £5 million in a growth round led by Venrex to scale US marketing, expand regional teams and add production capacity. The funding is intended to convert strong regional traction into broader national awareness in the US market.
The round underlines investor appetite for brands that can show demonstrable retail traction and disciplined, local expansion — metrics more likely to attract follow‑on capital than broad, unproven ambitions.
This week's Consumer & Retail deals:
Something & Nothing raised £5,000,000 in a growth round led by Venrex to scale US marketing, expand regional teams and add production capacity. The brand will use the funds to convert strong regional traction into broader national awareness in the US.
🎧 That's this week's Startupmag Weekly Briefing.
See you next Friday for another look at the UK startup scene.